story of the week
Genome-Wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer With VHL Loss
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Molecular Cell
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Genome-Wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer With VHL Loss
Mol. Cell 2020 Jan 29;[EPub Ahead of Print], X Liu, JM Simon, H Xie, L Hu, J Wang, G Zurlo, C Fan, TS Ptacek, L Herring, X Tan, M Li, AS Baldwin, WY Kim, T Wu, MW Kirschner, K Gong, Q ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.